Home > Cashflow Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Net Cash Inflow / Outflow

    Back to Cashflow Statement
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Cash Inflow / Outflow ₹799 Cr₹2,169 Cr₹-1,021 Cr₹223 Cr₹-1,164 Cr

What is the latest Net Cash Inflow / Outflow ratio of AUROBINDO PHARMA ?

The latest Net Cash Inflow / Outflow ratio of AUROBINDO PHARMA is ₹799 Cr based on Mar2026 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2026₹799 Cr
Mar2025₹2,169 Cr
Mar2024₹-1,021 Cr
Mar2023₹223 Cr
Mar2022₹-1,164 Cr

How is Net Cash Inflow / Outflow of AUROBINDO PHARMA Trending?

Years Net Cash Inflow / Outflow % Change
Mar2026 ₹799 Cr
-63.17
Mar2025 ₹2,169 Cr
Positive
Mar2024 ₹-1,021 Cr
Negative
Mar2023 ₹223 Cr
Positive
Mar2022 ₹-1,164 Cr -

Compare Net Cash Inflow / Outflow of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹105,010.5 Cr 2.1% 7.2% 62.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹454,914.0 Cr 3.9% 7.8% 13% Stock Analytics
DIVIS LABORATORIES ₹300,380.0 Cr 11.5% 20.6% 68% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,169.0 Cr 1% 1.8% 34.3% Stock Analytics
DR REDDYS LABORATORIES ₹114,933.0 Cr 1.1% 11.8% 14.9% Stock Analytics
CIPLA ₹114,478.0 Cr 1.1% 7.9% -6.3% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

2.1%

7.2%

62.2%

SENSEX

5.9%

13%

-1.9%


You may also like the below Video Courses